Biotage AB (publ) (BITGF)

Market Cap	1.20B
Revenue (ttm)	195.36M
Net Income (ttm)	25.40M
Shares Out	n/a
EPS (ttm)	0.32
PE Ratio	47.15
Forward PE	59.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	673
Open	15.02
Previous Close	15.07
Day's Range	15.02 - 15.02
52-Week Range	8.77 - 18.52
Beta	0.85
RSI	51.54
Earnings Date	Aug 6, 2025

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, parallel peptide purification, and work-up products; flash systems and accessories, and normal and reversed phase cartridges; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal and supported scavengers and reagents, as well as accessories and spare parts...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1969
• Employees: 680
• Stock Exchange: OTCMKTS
• Ticker Symbol: BITGF

Financial Performance

In 2024, Biotage AB's revenue was 2.06 billion, an increase of 10.42% compared to the previous year's 1.86 billion. Earnings were 284.00 million, an increase of 15.45%.

Financial numbers in SEK